サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1637060

がん栄養療法の世界市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2032年）

Oncology Nutrition Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032

出版日
ページ情報
英文 186 Pages
納期
2～5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=149.35円
がん栄養療法の世界市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2032年）
出版日: 2025年01月14日
発行: Fairfield Market Research
ページ情報: 英文 186 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

がんの有病率の上昇と専門的な栄養サポートの需要に牽引され、世界のがん栄養療法市場は大きな成長を遂げます。がん栄養療法の市場規模は2025年に28億3,000万米ドルに達し、8.60％のCAGRで拡大し、2032年までに50億4,000万米ドルまでさらに拡大すると予測されています。がん治療の進歩と患者ケアにおける栄養の役割に対する意識の高まりにより、この市場は有望な軌道に乗っています。

がん栄養療法は、がん治療を受けている患者特有の食事ニーズに対応するためのヘルスケア産業の専門分野です。がん治療ではしばしば、栄養不良、体重減少、免疫力の低下などの課題が生じます。がん栄養療法は、個別化された栄養戦略を通じてこれらの影響を緩和し、患者のQOLを向上させ、治療成果を支援することを目的としています。

世界のがん罹患率の上昇により、治療成績を向上させ、治療に関連する副作用を管理するために、患者に合わせた栄養サポートの必要性が強調されています。免疫療法や化学療法などの治療法の進歩により、補完的な栄養戦略の需要が高まっています。標的を絞ったサプリメントや免疫サポート成分を含む栄養製剤の革新により、がん栄養療法学の範囲が拡大しました。医療従事者および患者は、栄養が治療の有効性および全体的な幸福に及ぼす影響をますます認識するようになっています。

当レポートでは、世界のがん栄養療法市場について調査し、市場の概要とともに、がんタイプ別、最終用途別、地域別動向、および市場に参入する企業の競合動向などを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場の定義とセグメンテーション
  • 市場力学
  • バリューチェーン分析
  • ポーターのファイブフォース分析
  • COVID-19の影響分析
  • 経済概要
  • PESTLE分析

第3章 世界のがん栄養療法市場の見通し、2019年～2032年

  • 世界のがん栄養療法市場の見通し、がんタイプ別、金額（10億米ドル）、2019年～2032年
  • 世界のがん栄養療法市場の見通し、最終用途別、金額（10億米ドル）、2019年～2032年
  • 世界のがん栄養療法市場の見通し、地域別、金額（10億米ドル）、2019年～2032年

第4章 北米のがん栄養療法市場の見通し、2019年～2032年

第5章 欧州のがん栄養療法市場の見通し、2019年～2032年

第6章 アジア太平洋のがん栄養療法市場の見通し、2019年～2032年

第7章 ラテンアメリカのがん栄養療法市場の見通し、2019年～2032年

第8章 中東・アフリカのがん栄養療法市場の見通し、2019年～2032年

第9章 競合情勢

  • 企業市場シェア分析、2025年
  • 競合ダッシュボード
  • 企業プロファイル
    • Aceto
    • B. Braun Melsungen AG
    • Baxter
    • Fresenius Kabi AG
    • Hormel Foods Corporation
    • Mead Johnson & Company, LLC
    • Meiji Holdings Co., Ltd
    • Nestle S.A.
    • BioSig Technologies, Inc.
    • Auris Health, Inc.
    • その他

第10章 付録

目次

The global oncology nutrition market is set to experience significant growth, driven by the increasing prevalence of cancer and the demand for specialized nutritional support. The oncology nutrition market is projected to reach a valuation of $2.83 billion in 2025 and expand further to $5.04 billion by 2032, at a CAGR of 8.60%. With advancements in cancer treatments and a heightened awareness of the role of nutrition in patient care, this market is on a promising trajectory.

Market Insights Oncology nutrition is a specialized segment of the healthcare industry dedicated to addressing the unique dietary needs of individuals undergoing cancer treatment. Cancer therapies often result in challenges such as malnutrition, weight loss, and weakened immune systems. Oncology nutrition aims to mitigate these effects through personalized nutritional strategies, improving patients' quality of life and supporting treatment outcomes.

Key Growth Drivers

  • 1. Rising Cancer Prevalence: The increasing global burden of cancer underscores the need for tailored nutritional support to enhance treatment outcomes and manage therapy-related side effects.
  • 2. Advancements in Cancer Treatments: Progress in therapies like immunotherapy and chemotherapy has elevated the demand for complementary nutritional strategies.
  • 3. Focus on Research and Development: Innovations in nutritional formulations, including targeted supplements and immune-supportive ingredients, have expanded the scope of oncology nutrition.
  • 4. Awareness of Nutrition's Role: Healthcare providers and patients are increasingly recognizing the impact of nutrition on treatment efficacy and overall well-being.

Business Opportunities

  • 1. Digital Health Solutions and Remote Monitoring: The integration of telehealth platforms and mobile applications presents opportunities for real-time nutritional support and patient monitoring, enhancing accessibility and convenience.
  • 2. Personalized Nutrition Products: The development of tailored supplements and meal replacements to address specific patient needs, such as difficulty swallowing or taste alterations, is driving innovation.
  • 3. Regional Expansion: Emerging markets in South Asia and the Pacific, with their increasing healthcare awareness and rising cancer burden, present significant growth opportunities.

Regional Analysis

  • 1. Europe: Europe leads the market with its robust healthcare infrastructure and emphasis on holistic cancer care, including nutritional support.
  • 2. South Asia and the Pacific: This region is the fastest-growing market, driven by an alarming rise in cancer cases and increasing healthcare awareness.
  • 3. North America: With advanced healthcare systems and a high prevalence of cancer, North America remains a significant contributor to the market.

Recent Developments

  • 1. Product Launch: In July 2022, Nestle introduced its first Foods for Special Medical Purposes (FSMP) for cancer patients in China, following a rigorous five-year regulatory approval process.
  • 2. Innovative Funding: In January 2022, Faeth Therapeutics secured $47 million in a Series A financing round to advance clinical trials integrating nutrient control, drugs, and digital tools for cancer management.

Key Players The competitive Analysis of the oncology nutrition market includes prominent players such as:

  • Aceto
  • B. Braun Melsungen AG
  • Baxter
  • Fresenius Kabi AG
  • Global Health Products, Inc.
  • Hormel Foods Corporation
  • Mead Johnson & Company, LLC
  • Meiji Holdings Co., Ltd
  • Nestle S.A.
  • BioSig Technologies, Inc.
  • Auris Health, Inc.

Market Segmentation The oncology nutrition market is segmented as follows:

  • By Cancer Type: Head and Neck Cancers, Stomach and Gastrointestinal Cancers, Liver Cancer, Pancreatic Cancer, Esophageal Cancer, Lung Cancer, Breast Cancer, Blood Cancer, and Others.
  • By End-use: Hospitals & Clinics, Home Care, and Others.
  • By Region: North America, Europe, East Asia, South Asia & Oceania, Latin America, and the Middle East & Africa.

Table of Contents

1. Executive Summary

  • 1.1. Global Oncology Nutrition Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2025
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Economic Overview
    • 2.6.1. World Economic Projections
  • 2.7. PESTLE Analysis

3. Global Oncology Nutrition Market Outlook, 2019 - 2032

  • 3.1. Global Oncology Nutrition Market Outlook, by Cancer Type, Value (US$ Bn), 2019 - 2032
    • 3.1.1. Key Highlights
      • 3.1.1.1. Head and Neck Cancers
      • 3.1.1.2. Stomach and Gastrointestinal Cancers
      • 3.1.1.3. Liver Cancer
      • 3.1.1.4. Pancreatic Cancer
      • 3.1.1.5. Esophageal Cancer
      • 3.1.1.6. Lung Cancer
      • 3.1.1.7. Breast Cancer
      • 3.1.1.8. Blood Cancer
      • 3.1.1.9. Other Cancers
  • 3.2. Global Oncology Nutrition Market Outlook, by End Use, Value (US$ Bn), 2019 - 2032
    • 3.2.1. Key Highlights
      • 3.2.1.1. Hospitals & Clinics
      • 3.2.1.2. Home Care
      • 3.2.1.3. Others
  • 3.3. Global Oncology Nutrition Market Outlook, by Region, Value (US$ Bn), 2019 - 2032
    • 3.3.1. Key Highlights
      • 3.3.1.1. North America
      • 3.3.1.2. Europe
      • 3.3.1.3. Asia Pacific
      • 3.3.1.4. Latin America
      • 3.3.1.5. Middle East & Africa

4. North America Oncology Nutrition Market Outlook, 2019 - 2032

  • 4.1. North America Oncology Nutrition Market Outlook, by Cancer Type, Value (US$ Bn), 2019 - 2032
    • 4.1.1. Key Highlights
      • 4.1.1.1. Head and Neck Cancers
      • 4.1.1.2. Stomach and Gastrointestinal Cancers
      • 4.1.1.3. Liver Cancer
      • 4.1.1.4. Pancreatic Cancer
      • 4.1.1.5. Esophageal Cancer
      • 4.1.1.6. Lung Cancer
      • 4.1.1.7. Breast Cancer
      • 4.1.1.8. Blood Cancer
      • 4.1.1.9. Other Cancers
  • 4.2. North America Oncology Nutrition Market Outlook, by End Use, Value (US$ Bn), 2019 - 2032
    • 4.2.1. Key Highlights
      • 4.2.1.1. Hospitals & Clinics
      • 4.2.1.2. Home Care
      • 4.2.1.3. Others
  • 4.3. North America Oncology Nutrition Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
    • 4.3.1. Key Highlights
      • 4.3.1.1. Oncology Nutrition Market by Cancer Type, Value (US$ Bn), 2019 - 2032
      • 4.3.1.2. Oncology Nutrition Market by End Use, Value (US$ Bn), 2019 - 2032
      • 4.3.1.3. Canada Oncology Nutrition Market by Cancer Type, Value (US$ Bn), 2019 - 2032
      • 4.3.1.4. Canada Oncology Nutrition Market by End Use, Value (US$ Bn), 2019 - 2032
    • 4.3.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Oncology Nutrition Market Outlook, 2019 - 2032

  • 5.1. Europe Oncology Nutrition Market Outlook, by Cancer Type, Value (US$ Bn), 2019 - 2032
    • 5.1.1. Key Highlights
      • 5.1.1.1. Head and Neck Cancers
      • 5.1.1.2. Stomach and Gastrointestinal Cancers
      • 5.1.1.3. Liver Cancer
      • 5.1.1.4. Pancreatic Cancer
      • 5.1.1.5. Esophageal Cancer
      • 5.1.1.6. Lung Cancer
      • 5.1.1.7. Breast Cancer
      • 5.1.1.8. Blood Cancer
      • 5.1.1.9. Other Cancers
  • 5.2. Europe Oncology Nutrition Market Outlook, by End Use, Value (US$ Bn), 2019 - 2032
    • 5.2.1. Key Highlights
      • 5.2.1.1. Hospitals & Clinics
      • 5.2.1.2. Home Care
      • 5.2.1.3. Others
  • 5.3. Europe Oncology Nutrition Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
    • 5.3.1. Key Highlights
      • 5.3.1.1. Germany Oncology Nutrition Market by Cancer Type, Value (US$ Bn), 2019 - 2032
      • 5.3.1.2. Germany Oncology Nutrition Market by End Use, Value (US$ Bn), 2019 - 2032
      • 5.3.1.3. U.K. Oncology Nutrition Market by Cancer Type, Value (US$ Bn), 2019 - 2032
      • 5.3.1.4. U.K. Oncology Nutrition Market by End Use, Value (US$ Bn), 2019 - 2032
      • 5.3.1.5. France Oncology Nutrition Market by Cancer Type, Value (US$ Bn), 2019 - 2032
      • 5.3.1.6. France Oncology Nutrition Market by End Use, Value (US$ Bn), 2019 - 2032
      • 5.3.1.7. Italy Oncology Nutrition Market by Cancer Type, Value (US$ Bn), 2019 - 2032
      • 5.3.1.8. Italy Oncology Nutrition Market by End Use, Value (US$ Bn), 2019 - 2032
      • 5.3.1.9. Turkey Oncology Nutrition Market by Cancer Type, Value (US$ Bn), 2019 - 2032
      • 5.3.1.10. Turkey Oncology Nutrition Market by End Use, Value (US$ Bn), 2019 - 2032
      • 5.3.1.11. Russia Oncology Nutrition Market by Cancer Type, Value (US$ Bn), 2019 - 2032
      • 5.3.1.12. Russia Oncology Nutrition Market by End Use, Value (US$ Bn), 2019 - 2032
      • 5.3.1.13. Rest of Europe Oncology Nutrition Market by Cancer Type, Value (US$ Bn), 2019 - 2032
      • 5.3.1.14. Rest of Europe Oncology Nutrition Market by End Use, Value (US$ Bn), 2019 - 2032
    • 5.3.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Oncology Nutrition Market Outlook, 2019 - 2032

  • 6.1. Asia Pacific Oncology Nutrition Market Outlook, by Cancer Type, Value (US$ Bn), 2019 - 2032
    • 6.1.1. Key Highlights
      • 6.1.1.1. Head and Neck Cancers
      • 6.1.1.2. Stomach and Gastrointestinal Cancers
      • 6.1.1.3. Liver Cancer
      • 6.1.1.4. Pancreatic Cancer
      • 6.1.1.5. Esophageal Cancer
      • 6.1.1.6. Lung Cancer
      • 6.1.1.7. Breast Cancer
      • 6.1.1.8. Blood Cancer
      • 6.1.1.9. Other Cancers
  • 6.2. Asia Pacific Oncology Nutrition Market Outlook, by End Use, Value (US$ Bn), 2019 - 2032
    • 6.2.1. Key Highlights
      • 6.2.1.1. Hospitals & Clinics
      • 6.2.1.2. Home Care
      • 6.2.1.3. Others
    • 6.2.2. BPS Analysis/Market Attractiveness Analysis
  • 6.3. Asia Pacific Oncology Nutrition Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
    • 6.3.1. Key Highlights
      • 6.3.1.1. China Oncology Nutrition Market by Cancer Type, Value (US$ Bn), 2019 - 2032
      • 6.3.1.2. China Oncology Nutrition Market by End Use, Value (US$ Bn), 2019 - 2032
      • 6.3.1.3. Japan Oncology Nutrition Market by Cancer Type, Value (US$ Bn), 2019 - 2032
      • 6.3.1.4. Japan Oncology Nutrition Market by End Use, Value (US$ Bn), 2019 - 2032
      • 6.3.1.5. South Korea Oncology Nutrition Market by Cancer Type, Value (US$ Bn), 2019 - 2032
      • 6.3.1.6. South Korea Oncology Nutrition Market by End Use, Value (US$ Bn), 2019 - 2032
      • 6.3.1.7. India Oncology Nutrition Market by Cancer Type, Value (US$ Bn), 2019 - 2032
      • 6.3.1.8. India Oncology Nutrition Market by End Use, Value (US$ Bn), 2019 - 2032
      • 6.3.1.9. Southeast Asia Oncology Nutrition Market by Cancer Type, Value (US$ Bn), 2019 - 2032
      • 6.3.1.10. Southeast Asia Oncology Nutrition Market by End Use, Value (US$ Bn), 2019 - 2032
      • 6.3.1.11. Rest of Asia Pacific Oncology Nutrition Market by Cancer Type, Value (US$ Bn), 2019 - 2032
      • 6.3.1.12. Rest of Asia Pacific Oncology Nutrition Market by End Use, Value (US$ Bn), 2019 - 2032
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Oncology Nutrition Market Outlook, 2019 - 2032

  • 7.1. Latin America Oncology Nutrition Market Outlook, by Cancer Type, Value (US$ Bn), 2019 - 2032
    • 7.1.1. Key Highlights
      • 7.1.1.1. Head and Neck Cancers
      • 7.1.1.2. Stomach and Gastrointestinal Cancers
      • 7.1.1.3. Liver Cancer
      • 7.1.1.4. Pancreatic Cancer
      • 7.1.1.5. Esophageal Cancer
      • 7.1.1.6. Lung Cancer
      • 7.1.1.7. Breast Cancer
      • 7.1.1.8. Blood Cancer
      • 7.1.1.9. Other Cancers
  • 7.2. Latin America Oncology Nutrition Market Outlook, by End Use, Value (US$ Bn), 2019 - 2032
      • 7.2.1.1. Hospitals & Clinics
      • 7.2.1.2. Home Care
      • 7.2.1.3. Others
    • 7.2.2. BPS Analysis/Market Attractiveness Analysis
  • 7.3. Latin America Oncology Nutrition Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
    • 7.3.1. Key Highlights
      • 7.3.1.1. Brazil Oncology Nutrition Market by Cancer Type, Value (US$ Bn), 2019 - 2032
      • 7.3.1.2. Brazil Oncology Nutrition Market by End Use, Value (US$ Bn), 2019 - 2032
      • 7.3.1.3. Mexico Oncology Nutrition Market by Cancer Type, Value (US$ Bn), 2019 - 2032
      • 7.3.1.4. Mexico Oncology Nutrition Market by End Use, Value (US$ Bn), 2019 - 2032
      • 7.3.1.5. Argentina Oncology Nutrition Market by Cancer Type, Value (US$ Bn), 2019 - 2032
      • 7.3.1.6. Argentina Oncology Nutrition Market by End Use, Value (US$ Bn), 2019 - 2032
      • 7.3.1.7. Rest of Latin America Oncology Nutrition Market by Cancer Type, Value (US$ Bn), 2019 - 2032
      • 7.3.1.8. Rest of Latin America Oncology Nutrition Market by End Use, Value (US$ Bn), 2019 - 2032
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Oncology Nutrition Market Outlook, 2019 - 2032

  • 8.1. Middle East & Africa Oncology Nutrition Market Outlook, by Cancer Type, Value (US$ Bn), 2019 - 2032
    • 8.1.1. Key Highlights
      • 8.1.1.1. Head and Neck Cancers
      • 8.1.1.2. Stomach and Gastrointestinal Cancers
      • 8.1.1.3. Liver Cancer
      • 8.1.1.4. Pancreatic Cancer
      • 8.1.1.5. Esophageal Cancer
      • 8.1.1.6. Lung Cancer
      • 8.1.1.7. Breast Cancer
      • 8.1.1.8. Blood Cancer
      • 8.1.1.9. Other Cancers
  • 8.2. Middle East & Africa Oncology Nutrition Market Outlook, by End Use, Value (US$ Bn), 2019 - 2032
    • 8.2.1. Key Highlights
      • 8.2.1.1. Hospitals & Clinics
      • 8.2.1.2. Home Care
      • 8.2.1.3. Others
    • 8.2.2. BPS Analysis/Market Attractiveness Analysis
  • 8.3. Middle East & Africa Oncology Nutrition Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
    • 8.3.1. Key Highlights
      • 8.3.1.1. GCC Oncology Nutrition Market by Cancer Type, Value (US$ Bn), 2019 - 2032
      • 8.3.1.2. GCC Oncology Nutrition Market by End Use, Value (US$ Bn), 2019 - 2032
      • 8.3.1.3. South Africa Oncology Nutrition Market by Cancer Type, Value (US$ Bn), 2019 - 2032
      • 8.3.1.4. South Africa Oncology Nutrition Market by End Use, Value (US$ Bn), 2019 - 2032
      • 8.3.1.5. Egypt Oncology Nutrition Market by Cancer Type, Value (US$ Bn), 2019 - 2032
      • 8.3.1.6. Egypt Oncology Nutrition Market by End Use, Value (US$ Bn), 2019 - 2032
      • 8.3.1.7. Nigeria Oncology Nutrition Market by Cancer Type, Value (US$ Bn), 2019 - 2032
      • 8.3.1.8. Nigeria Oncology Nutrition Market by End Use, Value (US$ Bn), 2019 - 2032
      • 8.3.1.9. Rest of Middle East & Africa Oncology Nutrition Market by Cancer Type, Value (US$ Bn), 2019 - 2032
      • 8.3.1.10. Rest of Middle East & Africa Oncology Nutrition Market by End Use, Value (US$ Bn), 2019 - 2032
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Company Market Share Analysis, 2025
  • 9.2. Competitive Dashboard
  • 9.3. Company Profiles
    • 9.3.1. Aceto
      • 9.3.1.1. Company Overview
      • 9.3.1.2. Therapy Portfolio
      • 9.3.1.3. Financial Overview
      • 9.3.1.4. Business Strategies and Development
    • 9.3.2. B. Braun Melsungen AG
      • 9.3.2.1. Company Overview
      • 9.3.2.2. Therapy Portfolio
      • 9.3.2.3. Financial Overview
      • 9.3.2.4. Business Strategies and Development
    • 9.3.3. Baxter
      • 9.3.3.1. Company Overview
      • 9.3.3.2. Therapy Portfolio
      • 9.3.3.3. Financial Overview
      • 9.3.3.4. Business Strategies and Development
    • 9.3.4. Fresenius Kabi AG
      • 9.3.4.1. Company Overview
      • 9.3.4.2. Therapy Portfolio
      • 9.3.4.3. Financial Overview
      • 9.3.4.4. Business Strategies and Development
    • 9.3.5. Hormel Foods Corporation
      • 9.3.5.1. Company Overview
      • 9.3.5.2. Therapy Portfolio
      • 9.3.5.3. Financial Overview
      • 9.3.5.4. Business Strategies and Development
    • 9.3.6. Mead Johnson & Company, LLC
      • 9.3.6.1. Company Overview
      • 9.3.6.2. Therapy Portfolio
      • 9.3.6.3. Financial Overview
      • 9.3.6.4. Business Strategies and Development
    • 9.3.7. Meiji Holdings Co., Ltd
      • 9.3.7.1. Company Overview
      • 9.3.7.2. Therapy Portfolio
      • 9.3.7.3. Financial Overview
      • 9.3.7.4. Business Strategies and Development
    • 9.3.8. Nestle S.A.
      • 9.3.8.1. Company Overview
      • 9.3.8.2. Therapy Portfolio
      • 9.3.8.3. Financial Overview
      • 9.3.8.4. Business Strategies and Development
    • 9.3.9. BioSig Technologies, Inc.
      • 9.3.9.1. Company Overview
      • 9.3.9.2. Therapy Portfolio
      • 9.3.9.3. Financial Overview
      • 9.3.9.4. Business Strategies and Development
    • 9.3.10. Auris Health, Inc.
      • 9.3.10.1. Company Overview
      • 9.3.10.2. Therapy Portfolio
      • 9.3.10.3. Financial Overview
      • 9.3.10.4. Business Strategies and Development
    • 9.3.11. Others
      • 9.3.11.1. Company Overview
      • 9.3.11.2. Therapy Portfolio
      • 9.3.11.3. Financial Overview
      • 9.3.11.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations